BCD-054 (sampeginterferon beta-1a) / Biocad  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BCD-054 (sampeginterferon beta-1a) / Biocad
NCT02359877: Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif® and Avonex® in Healthy Volunteers

Completed
1
60
RoW
BCD-054, pegylated interferon beta 1a, Rebif, interferon beta 1a, Avonex
Biocad
Healthy
10/15
12/15

Download Options